Mazdutide (IBI362) is a gastrinoreceptor.
In terms of drug type, it belongs to the peptide class of drugs. This drug activates glucagon-like peptide - 1 receptor (GLP - 1R) and glucagon receptor (GCGR) and has multiple metabolic regulatory effects.
In terms of therapeutic applications, it is mainly used in the treatment of diseases such as type 2 diabetes and obesity. It reduces body weight by regulating appetite and energy metabolism while improving glycemic control. For example, in clinical trials, Mazdutide demonstrated favorable effects in lowering blood glucose levels and reducing patient weight.
Mazdutide, as a novel once-weekly GLP-1 and glucagon receptor dual, offers a wide range of potential health benefits for research test subjects. From improving glucose control and aiding weight management to promoting cardiovascular health and preserving neurological function.
Mazdutide presents a promising therapeutic approach for addressing various health conditions.
Product Application
- 1.Helps slow food leaving your stomach
- 2.Helps prevent your liver from making too much sugar
- 3.Helps the pancreas produce more insul when your blood sugar levels are high
- 4.Can help control blood glucose
- 5.Can reduce hyperglycemia, especially after meals
- 6.Can reduce fasting insul and fasting glucose
- 7.Can reduce hemoglobin A1c
- 8.Can decrease appetite and caloric intake, while inhibiting weight gain
- 9.Has been shown to lower triglyceride levels and oxidative stress from high LDL
Product Benefit
Acts on the appetite regulation center of the brain to reduce food intake by increasing satiety. Patients will feel fuller more easily and thus spontaneously reduce the amount of food they eat to control calorie intake.
It can increase energy expenditure. It raises the body's basal metabolic rate, allowing the body to burn more calories even at rest, helping the user to lose weight, a role that is particularly important for obese or overweight patients with type 2 diabetes.
Some studies have suggested a possible protective effect on the cardiovascular system. This may be through a variety of mechanisms such as improving cardiovascular risk factors such as blood glucose, blood pressure, and lipids, as well as reducing body weight to reduce the risk of cardiovascular disease. However this function needs to be confirmed by more research and clinical trials.
company profile
Hongbai Technology Co., Ltd. is a branch of Changsha Dolo Technology Co., Ltd.,which is a pioneering force in the biotechnology sector.
At the core of our operations is the unwavering commitment to our guiding principles : "Quality First, Service Supreme."Our mission is to spearhead advancements in biotechnology by consistently upholding the highest standards of quality and service. Through innovation and excellence, we aim to contribute to the betterment of global health and well-being.
Our primary focus encompasses a range of products , including weight loss peptideses, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Tirzepatide, Retatrutide, and others.Provides reliable and timely custom manufacturing services for API following stringent quality system and close communication with the Clients.We have professional sales team , focus on quality and service, and we have achieved excellent performance over the years. Our company is committed to the development of international market, our products are mainly exported to many countries and regions, such as Europe, America, South-east Asia, the Middle East and Africa etc.
With our constant efforts and good service, We sincerely hope to establish long-term cooperation and common development with our customers .